417 filings
D
AVTX
Avalo Therapeutics Inc
9 Apr 24
$199.98 mm in equity / options, sold $130.60 mm, 25 investors
4:58pm
10-K
2023 FY
AVTX
Avalo Therapeutics Inc
Annual report
29 Mar 24
4:05pm
8-K
AVTX
Avalo Therapeutics Inc
29 Mar 24
Avalo Reports 2023 Financial Results and Provides Business Updates
4:02pm
DEFA14A
AVTX
Avalo Therapeutics Inc
28 Mar 24
Additional proxy soliciting materials
6:26am
8-K
AVTX
Avalo Therapeutics Inc
28 Mar 24
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
6:08am
8-K
62butzhaq0hzz7s
31 Jan 24
Other Events
4:01pm
8-K
ek1gv78u spq6t
28 Dec 23
Avalo Therapeutics Announces 1-for-240 Reverse Stock Split
5:05pm
8-K
5qyp5r
20 Dec 23
Submission of Matters to a Vote of Security Holders
4:01pm
DEFA14A
8yot 9lk0rto1udz
7 Dec 23
Additional proxy soliciting materials
7:02am
8-K
63rvjx
7 Dec 23
Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split
7:01am
8-K
uetw9eh d8r
16 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7:15am
8-K
jz1urycr
9 Nov 23
Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates
7:04am
8-K
5i56wc j6r5
31 Oct 23
Avalo Completes Divestiture of AVTX-800 Series
7:21am
ARS
wkq9 zcpxutz661
19 Oct 23
Annual report to shareholders
4:15pm
DEFA14A
gh7tayp
19 Oct 23
Additional proxy soliciting materials
4:06pm
8-K
1pjv0mqbdcmpisdvvai4
17 Oct 23
Amendments to Articles of Incorporation or Bylaws
4:02pm
8-K
kurmr
3 Oct 23
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:05pm